the COMBO Endoscopy Oropharyngeal Airway
DeviceUsing the COMBO Endoscopy Oropharyngeal Airway for oxygenation.
NCT Number: NCT07012772
Hypoxia represents the prevailing adverse occurrence during the sedation of patients undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) with propofol. A recent innovation in this domain is the COMBO Endoscopy Oropharyngeal Airway-a multifaceted device that encompasses capnography monitoring, bite block , oxygenation support, and oropharyngeal airway management. This device has been purposefully designed to cater to the unique requirements of endoscopic procedures. The principal objective of this study is to assess the efficacy of the COMBO Endoscopy Oropharyngeal Airway in reducing the incidence of hypoxia in patients undergoing ERCP under sedation.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 2
The First Affiliated Hospital,Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Using the COMBO Endoscopy Oropharyngeal Airway for oxygenation.
Time frame: Patients will be followed for the duration of hospital stay, an expected average about 2 hours
75% ≤ SpO2 < 90% for <60 s
Time frame: Patients will be followed for the duration of hospital stay, an expected average about 2 hours
90% ≤ SpO2 < 95%
Time frame: Patients will be followed for the duration of hospital stay, an expected average about 2 hours
SpO2 < 75% or 75% ≤ SpO2 < 90% for ≥60 s
Time frame: Patients will be followed for the duration of hospital stay, an expected average about 2 hours
Other adverse events recorded by tools proposed by the World Society of Intravenous Anesthesia International Sedation Task Force
Contact information is provided by the study sponsor or research team.
DiSan Head of Anesthesiology, PhD
CONTACT
86+18616514088
Lianjuan Sun, Master
CONTACT
Zhejiang University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07051980
Biliary Tract Diseases, Choledocholithiasis With Cholecystitis With Obstruction
Hangzhou, Zhejiang, China
View Trial DetailsNCT07637721
Biliary Tract Diseases, Choledocholithiasis With Cholecystitis With Obstruction
Tianjin, Tianjin Municipality, China
View Trial DetailsNCT04213092
Choledocholithiasis With Acute and Chronic Cholecystitis, Choledocholithiasis With Cholecystitis With Obstruction
View Trial DetailsNCT00591968
Abdominal Aortic Aneurysm, Abnormal Uterine Bleeding
Punta Cana, La Altagracia Province, Dominican Republic
View Trial Details